Current treatment recommendation for lupus nephritis - Ponticelli - 1990 () Citation Context ... (Table 6). Discussion Although therapeutic strategies aimed at using low doses of corticosteroid and immunosuppressive agents during the inactive phases of SLE may reduce the side effects of therapy =-...
Current status and prospects of treatment for lupus nephritis 系统性红斑狼疮(systemic lupus erythematosus,SLE)是一常见的自身免疫性疾病,可累及多个器官和组织.肾脏是最常受侵犯的器官(几乎100%).目前,狼疮肾炎(lupus nephriti... 尹培达 - 《中华风湿病学杂志》 被引量: 0发表: 2002年 Update on the trea...
The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus Mycophenolate mofetil (MMF) has recently been introduced as an immunosuppressive agent for the treatment of glomerulonephritis with systemic lupus erythema... MY Weng,CT ...
erythematosuslupussystemictreatmentstatusvmr !"#$%"#& ’($&)&*#+ ,&-./ 012*+1 3 . 42.*&/#+ 5 !"#$%"#& 6 788898 : ;2--1.*2$<1$)1 /2= >?@A 4(B/ $5 C1+ = 87D E FG7H88I8J ,#K= 87D E FG7H897L J MBN#&+ = O#$%"(/ $ PQNGFL R )2N !"##$%& ...
Current status of treatment for systemic lupus erythematosus in China and its prospectSystemic Lupus ErythematosusSystemic Lupus Erythematosus PatientTotal Effective RateSystemic Lupus Erythematosus ActivationSevere Systemic Lupus Erythematosusdoi:10.1007/BF02934629Yang, Hutian...
The steroids may be given by mouth or intravenously. Also, high-dose corticosteroids (methylprednisolone) that are given in single, large doses (pulses) intravenously for three consecutive days are also a useful initial treatment for lupus nephritis, which is then followed by corticosteroids by ...
The treatment of the systemic lupus erythematosus (S.L.E.) has been modified significantly during the last years, contributing decisively to a better prognosis, and an increase in the life expectancy of patients. In this issue of the Acta Médica Portuguesa, we divulge our personal experience; ...
Patients with cutaneous lupus erythematosus (LE) are mainly seen by dermatologists. To evaluate the individual risk of severity and prognosis of the disease a precise classification including immuno serologic data is required. Risk factors for patients with chronic discoid or subacute cutaneous LE to ...
A major trend in the lupus treatment landscape is that many companies with approved therapies in other autoimmune diseases are testing them for efficacy in SLE and LN, as some of the symptoms are similar.Novartis’sCosentyx, with primary indications in psoriasis andaxial spondyloarthritis, is now ...
This review provides an overview of current and future treatments, discusses challenges in the SLE drug development process and offers recommendations for overcoming these challenges. 展开 关键词: systemic lupus erythematosus lupus nephritis interferon cytokines treatment ...